Nucleic acid and corresponding protein entitled 101P3A41...

Details Nucleic acid and corresponding protein entitled 101P3A41... Nucleic acid and corresponding protein entitled 101P3A41...

2007-04-24

2007-04-24

Siew, Jeffrey (Department: 1642)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S007230, C530S350000, C530S387100

Reexamination Certificate

active

10001469

ABSTRACT:
A novel gene (designated 101P3A11 and also referred to as PHOR-1) and its encoded protein are described. While 101P3A11 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed in prostate, colon and kidney cancers. Thus, 101P3A11 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 101P3A11 gene or fragment thereof, or its encoded protein or a fragment thereof, can be used to elicit an immune response.

REFERENCES:
patent: 6800746 (2004-10-01), Xu et al.
patent: 2002/0022248 (2002-02-01), Xu et al.
patent: 2002/0192763 (2002-12-01), Xu et al.
patent: 2003/0088059 (2003-05-01), Zozulya
patent: 2003/0113798 (2003-06-01), Brown et al.
patent: 2003/0213004 (2003-11-01), Jakobovits et al.
patent: 1270724 (2003-01-01), None
patent: WO 96/39435 (1996-12-01), None
patent: WO 99/06550 (1999-02-01), None
patent: WO 00/04149 (2000-01-01), None
patent: WO 00/20590 (2000-04-01), None
patent: WO-01/27158 (2001-04-01), None
patent: WO-01/73032 (2001-10-01), None
patent: WO-01/74904 (2001-10-01), None
patent: WO2002016548 (2002-02-01), None
patent: WO200261087 (2002-08-01), None
patent: WO200289747 (2002-11-01), None
patent: WO200292842 (2002-11-01), None
patent: WO2003009814 (2003-02-01), None
Bowie et al (Science, 1990, 257 : 1306-1310).
(Chang F et al, 2003, Leukemia, 17: 1263-1293.
Hummler E et al, 1994, PNAS, USA, 91: 5647-5661.
Xu Xin et al, 2001, FASEB J, 15(4): A313.
MPSRCH search report, us-10-001-469a.2866.rag, p. 10.
Alberts et al., Molecular Biology of the Cell, 3rd Edition (1994) p. 465.
Bepler et al., Genomics (1999) 55(2):164-175.
Burgess et al., Journal of Cell Biology (1990) 11:2129-2138.
EMBL Sequence Accession No. A06681.Gcg—Geneseq—D, Jun. 13, 2000 (first entry).
EMBL Sequence Accession No. AF101565, Jan. 29, 1999, Nov. 8, 2000.
Fu et al., EMBO Journal (1996) 15:4392-4401.
Gillies et al., Human Antibodies and Hybridomas (1990) 1(1):47-54.
Harrison, Immunol Series 49:411-464.
Hubert et al., Proc. Natl. Acad. Sci. USA (1999) 96(25):14523-14528.
Jansen, Pediatric Res. (1995) 37(6):681-686.
Klein et al., Nat. Med. (1997) 3:402.
Lazar et al., Molecular and Cell Biology (1988) 8:1247-1252.
Maniatis et al. (Eds.), Mol. Cloning (1989) Cold Spring Harbor Laboratory, Cold Spring Harbor, p. 17.31.
McLean and Hill, Eur.J. of Cancer (1993) 29A:2243-2248.
Nageneseq, EMBL Sequence Accession No. X40518, Jun. 18, 1999 (first entry).
Pinto et al., Clin. Cancer Res. (1996) 2(9):1445-1451.
Reiter et al., Proc. Natl. Acad. Sci. USA (1998) 95:1735.
Shantz and Pegg, Int. J. of Biochem. and Cell Biol. (1999) 31:107-122.
Sjogren, Immunotechnology (1997) 3(3):161-172.
Su et al., Proc. Natl. Acad. Sci. USA (1996) 93:7252.
Tao et al., The Journal of Immunology (1989) 143(8):2595-2601.
Supplementary Partial European Search Report for EP 02 73 6898, mailed on Oct. 4, 2005, 4 pages.

Affiliated with

Also associated with

Rating

Nucleic acid and corresponding protein entitled 101P3A41... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid and corresponding protein entitled 101P3A41..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid and corresponding protein entitled 101P3A41... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3743171